Posts Tagged ‘Bahamas’

Bahamian recording artist Sammi Starr launches “#Bahamas, Your Best Picture Deserves My Best Song”, a social media campaign celebrating his love for his country, his music and his roots

FacebookTwitterGoogle+Share

NASSAU, Bahamas, March 28, 2017 /PRNewswire/ – Bahamas-born Sammi Starr, Sony Music recording artist, is proud to announce the launch of “#Bahamas, Your Best Picture Deserves My Best Song”, a grassroots social media campaign aiming to share with the world Sammi’s love for his country and the sounds of its Junkanoo festival through his song “Jump in Da Line”, a single produced and remixed by Latin Grammy® winner, DJ Buddha.

Photo – http://mma.prnewswire.com/media/483261/Sony_Music_Sammi_Starr.jpg

Sammi Starr is launching “#Bahamas” on Tuesday, March 28th on his website www.sammistarrmusic.com as well as on Instagram. Sammi will search for his favorite photos and videos posted on Instagram with the hashtag #Bahamas and share them back with a soundtrack, his Bahamian Carnival anthem “Jump in Da Line” as well as an invitation to visit his web page. Fans can also add Sammi’s music to their photos themselves visiting www.sammistarrmusic.com.

“When you come to The Bahamas you are surrounded by beauty, music, culture, history and great vibes. I find thousands of pictures on Instagram of Bahamians and visitors having the time of their lives here. They inspired me to add my song “Jump in Da Line” as the soundtrack to their most vivid memories as we all celebrate together Junkanoo style through #Bahamas!” said Sammi.

“Jump in Da Line” is inspired by Junkanoo and it describes the Bahamian Junkanoo festival including the groups in formation and lines all moving to the sound of the rhythm. The song has received extensive airplay since its release and you can listen to it on the platform of your preference clicking here.

About Sammi Starr
Sammi Starr is a renowned Bahamian recording artist and producer in the Caribbean. Sammi landed a recording contract with Sony Music Latin for his single “Jump in Da Line” after winning the Music Masters Competition during the 2015 Bahamas Junkanoo Carnival organized by the Bahamas National Festival Commission. He represents The Bahamas with pride at international events throughout the Caribbean and in the United States. His style has been described as a unique blend of Marvin Gaye, Usher, Kanye West and John Legend with an island twist. For more information, please visit: www.sammistarrmusic.com

Click Here for More Information »

Ernst & Young Ltd. announces two senior leadership changes in Bermuda

David Brown appointed as Senior Partner in Bermuda and Regional Insurance Leader and Jessel Mendes named Regional Growth Markets Leader

HAMILTON, Bermuda, Nov. 1, 2016 /PRNewswire-HISPANIC PR WIRE/ — Ernst & Young Ltd. today announced two leadership changes. David Brown will become the firm’s Senior Partner in Bermuda and Insurance Leader for the EY Bahamas, Bermuda, British Virgin Islands and Cayman Islands region, replacing Pete Cangany, who will retire from EY after 37 years with the organization. This transition will take effect on July 1, 2017, and Cangany will remain in the role until that time. Effective immediately, Jessel Mendes will assume the new role of Regional Growth Markets Leader, in addition to his current responsibilities as Partner of Ernst & Young Ltd. (EY Bermuda).

Building a better working world logo

Brown most recently served as the Insurance Industry leader for the Southwest Region of Ernst & Young LLP in the US and directed the Southwest Region FSO Assurance practice. He has more than 27 years of experience working with large multinational clients, including insurance companies with global operations, US domestic insurance enterprises and Bermuda-based global reinsurance companies. Cangany has served as Senior Bermuda Partner since July 2014, and has been regional Insurance Leader since January 2013.

“Under Pete’s leadership, we have been able to build a high-performing team in Bermuda, enhance our relationships with stakeholders across the market and expand our range of services and expertise,” said Dan Scott, Regional Managing Partner for the EY region including Bahamas, Bermuda, the British Virgin Islands and the Cayman Islands. “We are very excited to have David assume this role and contribute to our legacy of leadership. His deep insurance and reinsurance experience, coupled with his knowledge of the market, will allow us to bring even more global resources to our Bermuda clients and help them capitalize on new opportunities. We are pleased to have Pete remain in the role through the end of June to provide guidance and assist in the transition process.”

In taking on the new role of Growth Markets Leader for the region, Jessel Mendes will be adding to his current responsibilities as EY Bermuda Partner. In addition to continuing to interact with EY Bermuda clients and other market stakeholders, as Growth Markets Leader he will focus on driving growth for EY firms across the region, maintaining a pulse on the market, overseeing the growth of EY service offerings, programs and initiatives, and determining how resources and capabilities can be best deployed to benefit clients. Mendes, who is a member of the board of the Bermuda Business Development Agency (BDA), will also leverage his extensive network of relationships to uncover new opportunities and help EY Bermuda and the region’s other firms build on their market position.

“We are positioned for the next phase of growth in Bermuda and across the region, so the timing for these changes is ideal,” added Scott. “We have been working diligently with Pete, David and our clients to lay the groundwork for a smooth transition. David has a deep understanding of the challenges organizations are facing and great insurance industry knowledge, so he was a natural choice to lead our Bermuda practice. With Jessel taking on a new role, we now have a great opportunity to serve our clients’ rapidly-evolving needs and accelerate growth.”

About EY

EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

This news release has been issued by Ernst & Young Ltd., Bermuda, a member of the global EY organization serving clients in Bermuda.

Logo – http://photos.prnewswire.com/prnh/20130701/NY40565LOGO-b

Click Here for More Information »

Cutting edge therapy for Psoriasis patients now available in the Caribbean

- Clinical trials with over 3,000 treated patients demonstrate its efficacy.

- Studies demonstrated that at least two thirds of the patients obtained 75% improvement of Psoriasis Activity Severity Index.

- This treatment significantly improves the quality of life of patients with moderate to severe plaque psoriasis.

PANAMA CITY, Dec. 2, 2015 /PRNewswire-HISPANIC PR WIRE/ – Psoriasis is a chronic skin disease that affects around 140 million people worldwide.  It’s more frequent between the ages of 15 and 25, but may develop at any age and highly impacts the quality of life.

Several types of psoriasis exist, which range from mild to severe and disabling. Plaque psoriasis is the most common form and is known for producing inflammation and scaly patches of thickened skin called “plaques”. It is caused due to a problem in the immunologic system, where white blood cells that normally become activated to fight infections, are in this case activated against the healthy skin cells.  The cause of the disease is unknown. The immunologic system is activated and produces inflammatory mediators which are responsible for the skin lesions.

During this process, white blood cells release chemical products called “cytokines”, which produce inflammation, reddening of the skin and make the cutaneous cells move from deeper skin layer to surface at a higher speed than normal, (almost 5 times). These cells accumulate and generate the scaly patches. Psoriatic lesions show the aspect of scales, sometimes with a white silver color, while the skin below is red and if scratched it can bleed. Two specific cytokines are increased in the pathogenesis of psoriasis and produce the inflammatory process of the disease (Interleukin 12 and Interleukin 23).

Ustekinumab is a monoclonal antibody that represents the first of a new class of psoriasis therapies that specifically and selectively targets IL-12/IL-23.

Ustekinumab is now available in the Caribbean, specifically in Aruba, Bahamas, Bermuda, Cayman Islands, Curacao and Jamaica.[i] Ustekinumab is commercialized under the brand Stelara™.

This therapeutic alternative is the latest generation of psoriasis treatment. With over 3,000 treated patients (in clinical trials) up to 5 years of treatment. The data obtained proves that the treatment is well tolerated and safe.

Clinical trials demonstrated that at least two thirds of the patients obtained a 75% improvement of the psoriasis, in accordance with the Psoriasis Activity Severity Index (PASI 75), after only two doses of Ustekinumab. This innovative treatment has a very convenient dosage regimen when compared with other biological therapies for psoriasis. After 5 years, approximately 80% of the patients treated with Ustekinumab maintain response.

Until recent years, psoriasis was considered a disease limited to the skin. Recent evidence, from important population studies in psoriatic patients, has demonstrated an increase in mortality and a decrease in life expectancy between 3 to 4 years in patients with psoriasis.

On the other hand, the impact of psoriasis notably influences the quality of life, and this is reflected in the increase of different social and psychoactive pathologies, and in the acquisition of unhealthy habits like tobacco and alcohol, favored by low self-esteem, anxiety, depression and the isolation which patients feel subjected to.[ii]

“Ustekinumab significantly improves the quality of life of patients with moderate to severe psoriasis, as well as their physical and mental functions. After 12 weeks of treatment, patients treated with Ustekinumab present a significant improvement in their mental well-being and their physical condition”, affirmed Dr. Eduardo Franco; Janssen’s Medical Director for Central America and the Caribbean.

The itching and pain, the plaques in their hands and feet may hinder the performance of certain tasks or participation in some activities. Overtime, about 40% of psoriatic patients develop arthritis. “The most severe cases of psoriasis may even generate immobility of the patient. Some patients compare the reduction of their physical activities to the ones generated by other diseases as cancer or heart diseases”, pointed out Dr. Jose Antonio Herrera, Immunology Medical Manager for Janssen.

About Janssen

Janssen is a Company dedicated to the research of providing innovative products that help protect and improve the life of people, and face and solve the most important and unresolved medical needs of our times, in the areas of oncology, immunology, neurosciences and infectious, cardiovascular and metabolic diseases.

Across the different companies of the Johnson & Johnson group, our people are united in the passionate pursuit of solutions through science, in benefit of the patients.

Present in over 50 countries, we share the commitment of the founders of the Company, of innovating in ideas, products and services for the patients of the whole world.

[i] Ustekinumab was approved by the following Health Authorities:
Aruba: Drug Registration Board,
Curacao; Drug Registration Board
Jamaica: Ministry of Health.
Cayman Islands, Bahamas and Bermuda are not regulated countries.

[ii] 2009 Latin American Psoriasis Consensus, treatment guides, Latin American Psoriasis Society

Fact Sheet Psoriasis

  1. Psoriasis is a chronic disease that affects over 140 million people worldwide.
  2. It presents itself more frequently between the ages of 15 and 25, but may develop at any age and highly impacts the quality of life.
  3. The main cause for this disease is unknown. The immunologic system is activated and produces inflammatory mediators which stimulated white cells and infiltrate the skin layers. The deep layer cells move to the outer layer of the skin at least 5 time faster than usual, and this produces the characteristic plaque of the psoriasis.
  4. There are several clinical forms of the disease, plaque psoriasis being the most common form. It is known for producing inflammation and scaly patches of thickened skin called “plaques”.
  5. Moderate to severe plaque psoriasis, notably influences the quality of life.  Severe cases of psoriasis may even generate immobility of the patient.
  6. Some patients compare the reduction of their physical activities to the ones generated by other diseases such as cancer or heart disease.
  7. Ustekinumab is now available in the Caribbean, specifically in Aruba, Bahamas, Bermuda, Caiman Islands, Curacao and Jamaica.[i]  Ustekinumab is commercialized under the brand Stelara™.
  8. Clinical trials with over 3,000 patients treated with Ustekinumab have demonstrated its efficacy. At least two thirds of the patients obtained a 75% improvement of the Psoriasis Activity Severity Index.
  9. After 5 years, approximately 80% of the patients treated with Ustekinumab maintain response.

[i] Ustekinumab was approved by the following Health Authorities:
Aruba: Drug Registration Board,
Curacao; Drug Registration Board
Jamaica: Ministry of Health.
Cayman Islands, Bahamas and Bermuda are not regulated countries.

CONTACT:  Janssen, JoanTownsend, (507) 64306252 or (507) 3989740, tojoa

Click Here for More Information »

Bahamian Supreme Court Grants Baha Mar Leave To Appeal Rejection Of Recognition Of U.S. Chapter 11 Proceedings

NASSAU, Bahamas, Aug. 4, 2015 /PRNewswire/ — Baha Mar today stated it is gratified that the Supreme Court of The Bahamas has granted leave to appeal the Court’s decision to reject Baha Mar’s application seeking the recognition of the U.S. Chapter 11 proceedings in the Delaware Court.

About Baha Mar

Baha Mar is set on 3,000 feet of white sandy beach just 10 minutes from Nassau’s fully renovated and expanded international airport.  It will feature elite hotels with gaming, entertainment, private residences, shopping and natural attractions that reflect an authentic Bahamian experience. Amenities will include a Jack Nicklaus Signature golf course; 200,000 square feet of flexible convention facilities, including a 2,000-seat entertainment venue; art galleries featuring Bahamian art; more than 40 restaurants, bars and clubs; global luxury designer and local artisan boutiques; and 20 acres of exquisitely landscaped beach and pool experiences, including a beachfront sanctuary with native Bahamian flora and fauna. For more information during this process please visit www.bmpathforward.com.

Media Contact

Kekst and Company
Jeremy Fielding/Stef Goodsell/Ross Lovern
Bahamar@Kekst.com
+1 (212) 521-4806

Click Here for More Information »

Johnson & Johnson Expands IP Policy to Create Broad Access in 128 Countries for Development of New and Optimized HIV Medicine Formulations for Children Living with HIV

Expanded Policy will Increase Access for Darunavir Pediatric Formulations in 128 Resource-Limited Countries

– Trinidad and Tobago, Antigua, Aruba, Bahamas, Barbados and Jamaica are some of the countries that would benefit with this policy

PANAMA CITY, May 14, 2015 /PRNewswire/ — Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have furthered their commitment to improve the health of children living with HIV through an expanded policy aimed at enhancing access to its HIV medicine darunavir. This policy enables the development of and access to new pediatric products of darunavir in 128 low- and middle-income countries[i], home to 99.8% of children and adolescents living with HIV worldwide[ii] today.

As part of efforts to help meet the needs of children and adolescents living with HIV, Janssen is working to create one of the broadest geographic territories for an access effort for pediatric HIV medicines to date. To that end, Janssen will expand the geographic scope of its 2012 policy not to enforce the patents it owns and controls on the antiretroviral (ARV) drug darunavir, for pediatric products used in low- and middle-income countries. This doubles the original territory of sub-Saharan Africa and Least Developed Countries[iii] announced in 2012. The 2012 policy outlines that Janssen will not enforce its darunavir patent rights, provided the generic versions of darunavir are quality, medically acceptable, and only used in the indicated countries. Today’s expanded policy is applicable only for pediatric darunavir products used in the defined territory. Manufacturers are still responsible for obtaining permissions from other darunavir patent holders and health authorities where appropriate.

These renewed efforts are an outcome of engagement between Janssen and the Medicines Patent Pool (MPP), directly supporting the recently-launched Pediatric HIV Treatment Initiative (PHTI). PHTI is a partnership between the MPP, UNITAID, the Drugs for Neglected Diseases initiative (DNDi) and the Clinton Health Access Initiative (CHAI) dedicated to speeding the development of high-priority pediatric co-formulations of HIV medicines and addressing other potential barriers to treatment access for children living with HIV.

Janssen will collaborate with PHTI partners to develop critical new formulations of pediatric HIV medicines to help safeguard the lives of children and adolescents living with HIV. Janssen and PHTI organizations will explore the possible development of a fixed-dose combination (FDC) of darunavir with the boosting agent ritonavir for children living with HIV. Darunavir administered with ritonavir and in combination with other antiretroviral medicines is currently indicated for highly treatment-experienced adult and pediatric HIV patients (third-line) in resource-limited settings and has been recommended by the World Health Organization[iv].  A novel FDC that is safe, effective and child-friendly would be an important step in realizing the global health imperative to close the pediatric HIV treatment gap.

“Our vision is that children living with HIV can receive the treatments they need to stay strong and grow to become productive young adults,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson and Worldwide Chairman, Janssen. “We are committed to ensuring that no child is without access to appropriate, child-friendly HIV treatment options and, most importantly, the hope of a healthy future.”

“Finding innovative solutions for the challenges of pediatric HIV treatment requires us all to think differently and act collaboratively,” said Tomas Matthews, Access Director, Janssen Global Public Health. “We are working to address obstacles in efforts to help protect the health of vulnerable children living with HIV in high-burden countries in Latin America and the Caribbean, and elsewhere around the world.”

Janssen and Johnson & Johnson have a longstanding commitment to helping children living with HIV and enhancing access to its medicines for thosein need. For more than a decade, Johnson & Johnson has supported efforts to reduce the number of new HIV infections among children, and in 2011, the company pledged an additional $15 million to support the Global Plan to eliminate pediatric HIV. In December 2013, Janssen launched the New Horizons Advancing HIV Care initiative, a collaborative effort to strengthen country-level capacity, knowledge, and action around the needs of HIV treatment-experienced children. A key feature of this initiative is a treatment donation program for PREZISTA® (darunavir) and INTELENCE® (etravirine) for HIV treatment-experienced children and adolescents.

Johnson & Johnson and Janssen are committed to advancing global health. Its family of companies has launched and continues to support a variety of comprehensive efforts toward strengthening the health of communities, improving maternal and child health, and preventing the spread of infectious and preventable diseases worldwide. For more information on Johnson & Johnson global health programs, visit www.jnj.com.

About Janssen, the Pharmaceutical Companies of Johnson & Johnson

At Janssen, we are dedicated to addressing and solving the most important unmet medical needs of our time, including in oncology (e.g., multiple myeloma and prostate cancer), immunology (e.g., rheumatoid arthritis, IBD and psoriasis), neuroscience (e.g., schizophrenia, dementia and pain), infectious disease (e.g., HIV/AIDS, Hepatitis C and tuberculosis), and cardiovascular and metabolic diseases (e.g., diabetes).

Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. To learn more, visit www.janssen.com.

About Johnson & Johnson

Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science ‒ bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 126,500 employees at more than 265 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

References

[i] In addition to all Least Developed Countries (LDCs) as defined by the United Nations and the countries of sub-Saharan Africa (SSA), countries included in this policy expansion are Algeria, American Samoa, Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Belize, Bolivia, British Virgin Islands, Colombia, Costa Rica, Cuba, Democratic People’s Republic of Korea, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, Fiji, Grenada, Guatemala, Guyana, Honduras, India, Indonesia, Iran, Iraq, Jamaica, Jordan, Lebanon, Libya, Malaysia, Marshall Islands, Micronesia, Moldova, Mongolia, Montserrat, Morocco, Nauru, Nicaragua, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Sri Lanka, Suriname, Syrian Arab Republic, Thailand, Tonga, Trinidad and Tobago, Tunisia, Turks and Caicos, Ukraine, Uruguay, Venezuela, Vietnam, and West Bank and Gaza.

[ii] Calculated using data from: UNICEF. Children, Adolescents and AIDS (2014 Statistical Update). http://www.childrenandaids.org/

[iii] Resource-limited settings under this policy include all Least Developed Countries (”LDCs”) as defined by the United Nations (http://www.unohrlls.org/en/ldc/25/) and the countries of sub-Saharan Africa (SSA) which are not classified as LDCs.

[iv] World Health Organization. Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach, 2010 Revision. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf

CONTACT:  Joan Townsend, Janssen Communication Manager, tojoan01@its.jnj.com

Click Here for More Information »

Kennedy Funding Completes $5.17 Million Financing for Historic Bahamas Property

Waterfront site was once the family compound and estate of the Parker Brothers of Monopoly fame

ENGLEWOOD CLIFFS, N.J., March 21, 2014 /PRNewswire/ – Kennedy Funding has completed a $5.17 million loan by Grand Pointe Lender Ltd. to borrower Grand Pointe Investments, Ltd. The four-year-interest only financing is secured by four oceanfront residential parcels with five residences and additional land, altogether totaling 15.5 acres, on Man O War Cay, Sea Glass Found, Abaco, Bahamas. Each of the five residential parcels consists of a main residence and a guest cottage.

“The property has a very interesting history,” said Kevin Wolfer, president and CEO of Kennedy Funding, the Englewood, NJ-based direct private lender. “It consists of the long-time former family compound and estate of the Parker Family of Parker Games fame–Monopoly and other well-known board games.”

The Orlando, FL-based Grand Pointe Investments, headed by John C. Gray, Jr., acquired the property 10 years ago from the Parker Family and, “has made extensive improvements since,” said Wolfer. “With 15.5 acres and five private beaches on its own peninsula, this property is clearly the ‘jewel of the Abacos.’”

The borrower has been restoring the Parker Family compound and estate, and intends to retain ownership of one of the five residences while marketing the others for sale. Because of the site’s historic significance and prime location, the project has required close cooperation with the local district council and the Bahamian government.

Now known as Sea Glass Found, the $20 million project is well underway, an effort that includes restoring the site’s harbor and marina. The latter effort will allow berthing for yachts up to 140 feet in length and averaging 80-90 feet to dock safely in a protected “hurricane hole.”

The financing will be utilized by the borrower to retire $3.5 million of existing debt, and the remainder for working capital–the borrower’s other properties include two office condominiums in Lake Mary, FL, and 42 single-family lots at Stone Island, Enterprise, FL.

Kennedy Funding, America’s leading direct private lender, specializes in bridge loans for commercial property and land acquisition, development, workouts, bankruptcies, and foreclosures. The principals of the company have closed over $2.5 billion in loans to date. The firm’s creative financing expertise enables the closing of equity-based loans of up to a 70% loan-to-value ratio, from $1 million to more than $50 million, in as little as five days. Kennedy Funding continues to actively seek new funding opportunities throughout the world.

www.kennedyfunding.com

CONTACT: David Green, davidgreen@resultsinc.com, 201-288-7888

Click Here for More Information »

Cummins Power South names Tess Truck & Equipment Sales and Services as an official Cummins Power Generation dealer in the Bahamas

ATLANTA, Oct. 2, 2013 /PRNewswire/ – In April of this year, Cummins Power South announced plans for the expansion of its Cummins Power Generation business in the Caribbean.  A vital part of the Caribbean expansion focuses on partnering with local businesses in the area to provide customers with Cummins world class support and exceptional service.  Cummins Power South is pleased to announce Tess Truck & Equipment Sales and Services as the official Cummins Power Generation dealer in the Bahamas.

Tess Truck & Equipment Sales and Services has been in business since the early 1970s providing industrial vehicles and equipment to the Bahama islands through their flagship of Bahamas Mack.   Expanding upon their product offering, Tess Truck & Equipment Sales and Services will now provide the full line of Cummins Power Generation products from residential and light commercial generators to commercial generator sets and power systems.  As the infrastructure in the Bahamas continues to grow, Tess Truck & Equipment Sales & Services, with the support of Cummins Power South, will help meet the energy needs of expanding industries such as healthcare, hospitality, government and water management as well as supply dependable backup emergency power for residential homes and communities throughout the islands.  Tess Truck & Equipment Sales and Services will serve as the main source of Cummins Power Generation sales and service, offering legendary Cummins service as the only certified Cummins Power Generation dealer in the Bahamas.

Detailed information on Cummins Power South and the expansion in the Bahamas may be obtained by visiting the company’s website at www.cumminspowersouth.com/bahamas/ .

Established in 2006, Cummins Power South, LLC is a joint venture distributorship within the Cummins North American Distributor System. Cummins Power South specializes in the sales and service of all Cummins engines, generators and related products within Georgia, Florida, and Chattanooga, Tennessee, as well as selected areas of the Caribbean.  Cummins Power South is headquartered in Atlanta, Georgia (USA) with service locations in Atlanta, Albany, Augusta, Gainesville, Savannah, Fort Myers, Jacksonville, Miami, Ocala, Orlando, Tampa, West Palm Beach and Chattanooga, TN. Additional information about the company may be found at www.cumminspowersouth.com

Click Here for More Information »

Cummins Power South has been named the official Cummins Power Generation distributor in the Bahamas and Turks & Caicos

ATLANTA, April 10, 2013 /PRNewswire/ – Cummins Power South today announced plans for expansion in the Caribbean as the official Cummins Power Generation distributor for the Bahamas and Turks & Caicos.  Through a network of dealer and distributor locations in Florida, Georgia, Chattanooga, TN and parts of the Caribbean, Cummins Power South provides sales and service expertise for Cummins diesel engines, power generation products and Cummins Genuine Parts throughout its territory.

While the company has maintained a presence within the Caribbean through local dealers who specialize in the sales and service of Cummins marine engines and generators, the company plans to grow its power generation business over the next year by providing dedicated support for Cummins commercial and residential generators.  David Hagewood, Vice President of Power Generation Sales and Marketing stated, “We are pleased to have the opportunity to serve the generator needs of the Bahamas and Turk & Caicos Islands.  We look forward to partnering with local businesses to provide world class support of Cummins Power Generation products and providing the exceptional customer service for which Cummins is well known.”

Detailed information on the company and the expansion in the Bahamas and the Turks and Caicos may be obtained by visiting the company’s website at www.cumminspowersouth.com/bahamas/.

Established in 2006, Cummins Power South, LLC is a joint venture distributorship within the Cummins North American Distributor System. Cummins Power South specializes in the sales and service of all Cummins engines, generators and related products within Georgia, Florida, and Chattanooga, Tennessee, as well as selected areas of the Caribbean.  Cummins Power South is headquartered in Atlanta, Georgia (USA) with service locations in Atlanta, Albany, Augusta, Gainesville, Savannah, Fort Myers, Jacksonville, Miami, Ocala, Orlando, Tampa, West Palm Beach and Chattanooga, TN. Additional information about the company may be found at www.cumminspowersouth.com

Click Here for More Information »

2011 Caribbean HIV Conference Attracts More Than 2,000 Participants From Across the Region

– HIV stakeholders from across the Caribbean will convene beginning this evening to focus on forging a sustainable response to the regional epidemic

 – Opening ceremony to feature keynote from The Honorable Hubert Alexander Ingraham, Prime Minister of The Commonwealth of The Bahamas, and performance by actress, singer, and activist Sheryl Lee Ralph

NASSAU,  Bahamas, Nov. 18, 2011 /PRNewswire/ — The 2011 Caribbean HIV Conference: Strengthening Evidence To Achieve Sustainable Action will commence this evening with more than 2,000 individuals from across the region in attendance. These individuals represent a wide range of interests, perspectives, and backgrounds, but they all share a common goal — to take part in forming a collaborative and sustainable response to the HIV epidemic in the Caribbean region.

The 2011 Caribbean HIV Conference will take place November 18–21, 2011, at the Atlantis Conference Center in Nassau, The Bahamas.

Tonight’s opening ceremony will feature a keynote address from The Right Honorable Hubert Alexander Ingraham, Prime Minister of The Commonwealth of The Bahamas, as well as a performance by acclaimed actress, singer, and activist Sheryl Lee Ralph of the United States. Best known for creating the role of Deena Jones in the Broadway musical Dreamgirls, Ms. Ralph will perform Sometimes I Cry, her one-woman play about women infected with and affected by HIV. 

The opening ceremony also will include:

  • Remarks from the three Conference Co-Chairs about the unique opportunity this conference provides; how the conference was developed; and its history, goals, and expected outcomes
  • An invocation from The Most Reverend Patrick Christopher Pinder, Archbishop of Nassau
  • A performance by the Bahamas National Youth Choir
  • Video messages from individuals across the Caribbean speaking about why the conference is needed and why they are taking part
  • Achievement awards presented by the Pan Caribbean Partnership Against HIV and AIDS and the International Treatment Preparedness Coalition
  • An award presentation to The Honorable Donna M. Christensen, U.S. Virgin Islands Delegate to Congress, for her years of service in the fight against HIV

“This evening’s opening ceremony is designed to provide attendees with an informative, dynamic, and culturally meaningful introduction to the conference,” said Conference Co-Chair Prof. Daisy M. Gely of the Medical Sciences Campus, University of Puerto Rico. “We are all looking forward to marking the beginning of a collaborative and productive 4 days.”

Focused on Sustainability

The theme for this year’s conference, Strengthening Evidence To Achieve Sustainable Action, focuses on identifying a viable path that can be maintained in the future regional response to HIV. “In the process of identifying the theme for this Conference, we reviewed the Caribbean’s HIV experience over the last three decades or so, and identified two critical and related concepts that we felt should be central to the Conference program — sustainability and the importance of evidence in guiding the strategies that will attain this goal,” said Conference Planning Committee member Roger McLean of the University of the West Indies at St. Augustine, Trinidad and Tobago. “Sustainability is a key challenge facing the regional HIV response, and, to confront it effectively, we need to carefully evaluate what has and hasn’t worked well previously, share good practices and lessons learned, and work together in their application through more integrated approaches.”

The theme is woven throughout the conference agenda. It is incorporated into each of five program tracks, and it is the focus of the following sessions:

  • Sustainability Issues. Sunday, November 20, 9:00 a.m.–10:30 a.m.
  • Sustainability–Sustainable Caribbean HIV Conferences. Sunday, November 20, 11:00 a.m.–12:30 p.m.
  • Ensuring Sustainability: Increasing Funding for Community-Based Organizations To Fight HIV in the Caribbean. Sunday, November 20, 5:00 p.m.–6:30 p.m.
  • Small Island States–Issues, Challenges, and Opportunities. Monday, November 21, 9:00 a.m.–10:30 a.m.
  • Winning the Fight on HIV/AIDS in the Caribbean: How Partnering With Business Can Yield Significant Impact. Monday, November 21, 9:00 a.m.–10:30 a.m.

A major objective is that the conference will establish a special committee that will present preliminary recommendations to form the basis for a sustainability action plan. “We see the conference itself as a key component in the future,” said Conference Planning Committee member Osborne Nurse, who will lead the Caribbean HIV Conference’s special session on sustainability. “We see it as an activity that can dovetail into a regional strategic framework and be aligned with one or more of the key strategic objectives of such a plan.”

More About the 2011 Caribbean HIV Conference

This event is the third Caribbean HIV conference in the past decade, and it is designed to build on successes of the previous events, which demonstrated that regional cooperation and collaboration are key to confronting HIV in the Caribbean. Leading political, scientific, and public health leaders are included in the impressive roster of speakers contributing to the agenda.

Visit https://www.2011caribbeanhivconference.org/2011-caribbean-hiv-conference-speakers-announced to view a list of some of the featured speakers and session moderators.

The conference will be conducted in English and Spanish. To view the full conference program, visit http://www.2011CaribbeanHIVConference.org/agenda.

The 2011 Caribbean HIV Conference is sponsored by the Government of The Commonwealth of The Bahamas; Medical Sciences Campus, University of Puerto Rico; and the Office of AIDS Research, National Institutes of Health (NIH), U.S. Department of Health and Human Services. Prof. Gely’s Conference Co-Chairs are Dr. Perry Gomez, Director, National AIDS Programme, Princess Margaret Hospital, Ministry of Health, The Commonwealth of The Bahamas; and Dr. Jack Whitescarver, NIH Associate Director for AIDS Research and Director, Office of AIDS Research, NIH, U.S. Department of Health and Human Services, United States.

Partners for the conference include: Caribbean Community (CARICOM); Caribbean Health Research Council (CHRC); Caribbean Regional Network of People Living With HIV/AIDS (CRN+); Caribbean Treatment Action Group (CTAG); Caribbean Vulnerable Communities (CVC) Coalition; Joint United Nations Programme on HIV/AIDS (UNAIDS); Kerzner International; National Minority AIDS Council (NMAC); Pan American Health Organization/World Health Organization (PAHO/WHO); Pan Caribbean Partnership Against HIV and AIDS (PANCAP); U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Trans-Caribbean HIV/AIDS Research Initiative (TCHARI); and The University of the West Indies (UWI).

 About HIV in the Caribbean

Although it varies from country to country, adult HIV prevalence in the Caribbean is approximately 1 percent, which is higher than that of any region of the world outside of Sub-Saharan Africa (UNAIDS 2010 Global Report). While the overall response to HIV in the Caribbean has improved, other health challenges and the impact of natural disasters affect the available resources for people living with the disease. Unprotected sex between men and women — especially paid sex — is thought to be the main mode of HIV transmission in this region (UNAIDS 2010 Global Report).

Members of the media are invited to visit the conference Web site and Flickr gallery throughout the event; updates and new photos will be added each day:

 Web Site: https://www.2011caribbeanhivconference.org/

Flickr: http://www.flickr.com/photos/2011caribbeanhivconference/

Click Here for More Information »

2011 Caribbean HIV Conference Designed To Explore Cross-Cutting Issues

Conference provides multidisciplinary forum for HIV stakeholders in the Caribbean to learn and exchange ideas about the most pressing issues facing the region

 NASSAU, The Bahamas, Oct. 27, 2011 /PRNewswire/ — The 2011 Caribbean HIV Conference: Strengthening Evidence To Achieve Sustainable Action, November 18–21, will bring together approximately 2,000 individuals from across the Caribbean to review research findings, to learn about best practices and skills-building tools, and to participate in networking opportunities. The program also will address regional cross-cutting issues, including:

-          Capacity-Building

-          Gender Issues

-          Human Rights

-          Research To Inform Action

-          Sustainability

-          Youth

To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/52865-2011-caribbean-hiv-conference

“By focusing our agenda on these issues, we’ve created a program that’s relevant to multiple stakeholders and will allow participants to build on their learnings as they attend different conference sessions,” said Conference Co-Chair Prof. Daisy M. Gely of the Medical Sciences Campus, University of Puerto Rico. “Presenters close to the issues facing the HIV community in the Caribbean will share expertise and research findings with reproducible results to provide a rich experience that will help us move forward collectively to best address the regional epidemic.”

These cross-cutting issues are woven throughout five program tracks:

-          Track A: Special Populations

  • The conference has multiple sessions discussing the unique considerations for populations such as MSM (men who have sex with men), substance users, youth, children, women, and sex workers, among others.

-          Track B: Legal, Ethical, Cultural, Spiritual, and Leadership Issues

  • Cultural, spiritual, and societal factors affect HIV stakeholders across the region. Conference-goers will have an opportunity to attend sessions highlighting the importance of these issues in the community. This track also seeks to promote leadership and sustainability at the national, regional, community, and individual levels.

-          Track C: Epidemiology, Basic Science, and Vaccine Research

  • The conference will explore the latest techniques, research findings, and management of HIV, which include considerations for coexisting infections, a significant public health concern in the Caribbean.

-          Track D: Treatment, Care, and Support

  • Treatment, care, and support are all vital components of achieving good outcomes for individuals with HIV. The conference will explore new approaches, best practices, social and economic influences, and other aspects of treatment, care, and support for individuals of various demographic backgrounds across the region.

-          Track E: Prevention: Social, Behavioral, and Biomedical Change

  • HIV prevention is a regional and global priority. Attendees will discuss social, behavioral, and biomedical research and strategies to reduce transmission.

Leading political, scientific, and public health leaders are included in the impressive roster of speakers contributing to the agenda. Visit https://www.2011caribbeanhivconference.org/2011-caribbean-hiv-conference-speakers-announced to view a list of some of the featured speakers and session moderators.

This event is the third Caribbean HIV conference in the past decade, and it is designed to build on successes of the previous events, which demonstrated that regional cooperation and collaboration are key to confronting HIV in the Caribbean. The multidisciplinary forum is designed to support local interests and education and is open and free of charge to anyone who would like to attend.

The conference will be conducted in both English and Spanish. To view the full conference program, visit http://www.2011CaribbeanHIVConference.org/agenda. To register, go to https://www.2011caribbeanhivconference.org/Registration.

Members of the media are also invited to attend. For information about how to register as a media representative, visit https://www.2011caribbeanhivconference.org/Media%20Information.

Please Note: Media members must create an account prior to submitting a registration form. Additionally, media interested in attending must register with the Bahamas Information Services office. More information can be found at: https://www.2011caribbeanhivconference.org/Media%20Information

More About the 2011 Caribbean HIV Conference

The 2011 Caribbean HIV Conference will take place November 18–21, 2011, at the Atlantis Conference Center in Nassau, The Bahamas.

The conference is sponsored by the Government of The Commonwealth of The Bahamas; Medical Sciences Campus, University of Puerto Rico; and the Office of AIDS Research, National Institutes of Health (NIH), U.S. Department of Health and Human Services. Prof. Gely’s Conference Co-Chairs are Dr. Perry Gomez, Director, National AIDS Programme, Princess Margaret Hospital, Ministry of Health, The Bahamas; and Dr. Jack Whitescarver, NIH Associate Director for AIDS Research and Director, Office of AIDS Research, NIH, U.S. Department of Health and Human Services.

 

Partners for the conference include: Caribbean Community (CARICOM); Caribbean Health Research Council (CHRC); Caribbean Regional Network of People Living With HIV/AIDS (CRN+); Caribbean Treatment Action Group (CTAG); Caribbean Vulnerable Communities (CVC) Coalition; Joint United Nations Programme on HIV/AIDS (UNAIDS); Kerzner International, National Minority AIDS Council (NMAC); Pan American Health Organization/World Health Organization (PAHO/WHO); Pan Caribbean Partnership Against HIV and AIDS (PANCAP); U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Trans-Caribbean HIV/AIDS Research Initiative (TCHARI); and The University of the West Indies (UWI).

About HIV in the Caribbean

Although it varies from country to country, adult HIV prevalence in the Caribbean is approximately 1 percent, which is higher than that of any region of the world outside of sub-Saharan Africa (UNAIDS 2010 Global Report). While the overall response to HIV in the Caribbean has improved, other health challenges and the impact of natural disasters affect the available resources for people living with the disease. Unprotected sex between men and women—especially paid sex—is thought to be the main mode of HIV transmission in this region (UNAIDS 2010 Global Report).

Click Here for More Information »

2011 Caribbean HIV Conference Speakers Announced

Conference provides free venue for HIV stakeholders in the Caribbean to network and to hear from some of the most well-respected names in HIV

 NASSAU, The Bahamas, Oct. 4, 2011 /PRNewswire/ — Distinguished experts, public officials, and HIV community members will come together at the 2011 Caribbean HIV Conference (November 18–21) to focus on HIV in the Caribbean, where adult HIV prevalence is higher than in any region in the world outside of Sub-Saharan Africa (UNAIDS 2010 Global Report). Individuals from across the Caribbean are invited to attend this free conference to hear directly from authorities on the medical, social, and socio-political factors influencing the HIV epidemic in this region. Featured speakers and session moderators will include, among others:

-          The Honorable Hubert A. Ingraham, Prime Minister of The Bahamas

-          The Honorable Sarah Wescot-Williams, Prime Minister of St. Maarten

-          Dr. Anthony S. Fauci, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), U.S. Department of Health and Human Services, United States

-          Dr.  Jean William Pape, Weill Cornell Medical College, Les Centres GHESKIO, Haiti

-          Dr. J. Peter Figueroa, The University of the West Indies at Mona, Jamaica

-          Dr. Ernest Massiah, Caribbean Regional Support Team, Joint United Nations Programme on HIV/AIDS, Trinidad and Tobago

-          Dr. Farley Cleghorn, Futures Group, United States

-          Ms. Geeta Sethi, United Nations Population Fund, Jamaica

 This event is the third Caribbean HIV conference in the past decade, and it is designed to build on successes of the previous events, which demonstrated that regional cooperation and collaboration are key to confronting HIV in the Caribbean. The multidisciplinary forum is designed to support local interests and education and is open to anyone who would like to attend, including:

  • people living with HIV
  • members of vulnerable groups
  • researchers and clinicians
  • allied health care professionals
  • caregivers
  • patient advocates
  • advocates for social justice and health parity
  • members of community- and faith-based organizations
  • regional and international governmental representatives
  • policy analysts and decision makers
  • civil society and regional media representatives

 ”The conference provides a unique opportunity for attendees with diverse perspectives and backgrounds to share, learn, and network,” said Conference Co-Chair Daisy M. Gely, Professor, Medical Sciences Campus, University of Puerto Rico. “It provides a venue in which to examine the many factors influencing HIV in the Caribbean in order to move forward collectively in our effort to prevent the spread of HIV, mitigate its impact in the region, and improve our overall response.”

 The conference will be conducted in both English and Spanish. To view the full conference program, visit http://www.2011CaribbeanHIVConference.org/agenda; to register, visit https://www.2011caribbeanhivconference.org/Registration.

 More About the 2011 Caribbean HIV Conference:

The 2011 Caribbean HIV conference will take place from November 18–21, 2011, at the Atlantis Conference Center in Nassau, The Bahamas.

 The conference is sponsored by the Government of The Commonwealth of The Bahamas; Medical Sciences Campus, University of Puerto Rico; and Office of AIDS Research, NIH, U.S. Department of Health and Human Services. In addition to Prof. Gely, Conference Co-Chairs are Dr. Perry Gomez, Director, National AIDS Programme, Princess Margaret Hospital, Ministry of Health, The Bahamas; and Dr. Jack Whitescarver, NIH Associate Director for AIDS Research and Director, Office of AIDS Research, NIH, U.S. Department of Health and Human Services.

Partners for the conference include: Caribbean Community (CARICOM); Caribbean Health Research Council (CHRC); Caribbean Regional Network of People Living With HIV/AIDS (CRN+); Caribbean Treatment Action Group (CTAG); Caribbean Vulnerable Communities (CVC) Coalition; Joint United Nations Programme on HIV/AIDS (UNAIDS); Kerzner International, National Minority AIDS Council (NMAC); Pan American Health Organization/World Health Organization (PAHO/WHO); Pan Caribbean Partnership Against HIV and AIDS (PANCAP); U.S. President’s Emergency Plan for AIDS Relief (PEPFAR); Trans-Caribbean HIV/AIDS Research Initiative (TCHARI); and The University of the West Indies (UWI).

Click Here for More Information »

Bahamas to Announce Shark Protections

NASSAU, THE BAHAMAS — On Tuesday, 5 July, the government of The Bahamas will announce new protections for sharks in the country’s waters, approximately 630,000 square kilometers (243,244 square miles). This declaration is the result of a partnership between the Pew Environment Group and The Bahamas National Trust, which began just as a major Bahamian seafood company announced its intention in September 2010 to catch sharks and export their fins.

 WHO:

Lawrence S. Cartwright, Minister of Agriculture and Marine Resources, The Bahamas

Earl Deveaux, Minister of Environment, The Bahamas

Eric Carey, executive director of The Bahamas National Trust (BNT)

Matt Rand, director of global shark conservation, Pew Environment Group

 WHAT:

Press conference announcing new protections for sharks in The Bahamas.

 WHY:

The Bahamas is one of the premier shark-watching destinations for divers. According to the Bahamas Diving Association, shark related tourism has contributed more than US$800 million dollars to the Bahamian economy over the past 20 years. The country’s 20-year-old ban on longline fishing gear has left Bahamian waters as one of the few places in the world where sharks are still thriving, but there have been no specific protections for sharks until now.

 WHEN:

8:00 a.m., Tuesday, 5 July, 2011

 WHERE:

British Colonial Hilton Nassau, 1 Bay Street, Nassau, N-7148

 CALL-IN:

Passcode is “Sharks”

1-800-311-9403 for U.S.-based reporters

1-800-867-1164 for Bahamas-based reporters

+1 334-323-7224 for all others

 PLEASE RSVP IN ADVANCE

 B-ROLL AND STILLS WILL BE AVAILABLE:
Contact: Dan Klotz, +1 202-887-8855 or dklotz@pewtrusts.org for details

Click Here for More Information »

Blackberry Travel App Is Now Available In Most Caribbean Markets

CaribPR Wire, MIAMI, FL, Weds. April 6, 2011: BlackBerry® Travel™, an application that provides BlackBerry® smartphone users with an all-in-one integrated tool to plan, book, manage and share travel activities quickly and easily, is now available in the major markets of the Caribbean.

The new app was recently announced in February at MWC 2011 in Barcelona and is now ready for download for BlackBerry users in the following markets: Trinidad and Tobago, Jamaica, Barbados, Puerto Rico, Bermuda, Bahamas, Aruba, Cayman Islands, Virgin Islands and US Virgin Islands.

The BlackBerry Travel app offers convenient push notifications and seamless integration of travel itineraries and flight status updates into the familiar BlackBerry Calendar.  When a new booking confirmation or itinerary arrives in the user’s email inbox, the BlackBerry Travel app is automatically updated with the relevant itinerary details, which makes travel planning and management easier than ever. With the BlackBerry push technology, the BlackBerry Travel app can keep users informed and in control of their itineraries by monitoring flight statuses and promptly providing notifications about changes to their flight information. The app can even identify potential omissions or scheduling concerns with their itineraries, such as missing accommodations or timing conflicts, and provide users with suggestions.

The BlackBerry Travel app also brings together tools that travelers need while planning on the go, including:

  • Hotel booking
  • Currency converters
  • Weather forecasts
  • Local search functionality

In addition, BlackBerry smartphone users can share their travel information with colleagues, friends and family over email or through LinkedIn®, directly from the BlackBerry Travel app. The LinkedIn integration allows users to search for people in their network who will be in the same city, send messages to contacts and update their status.

The BlackBerry Travel app also features a web component that allows users to book flights and car rentals, as well as edit and print itineraries, from their computer.

The BlackBerry Travel app was built in collaboration with WorldMate, a leader in mobile travel platforms.  WorldMate and RIM are working together with leaders in the travel industries such as Continental Airlines, Expedia Affiliate Network, Hilton Worldwide, Starwood Hotels and Resorts, United Airlines to provide BlackBerry Travel app users with an amazing mobile experience.

The BlackBerry Travel app will be available as of today from BlackBerry App World™ (www.blackberry.com/appworld). The app is free and works on select BlackBerry smartphones running the BlackBerry® 5 OS (Device Software) or higher.* For more information please visit www.blackberry.com/travel

* BlackBerry Travel is available at launch for the BlackBerry® Bold™, BlackBerry® Curve™, BlackBerry® Storm™ and BlackBerry® Torch™ series of smartphones.

Click Here for More Information »

10.74% of Shares of ICD Utilities Limited Acquired by Emera Inc.

GRAND BAHAMA, Bahamas, Dec. 22, 2010 /PRNewswire/ — ICD Utilities Limited (ICD – BISX) announced today the closing of the transfer of 1,073,917 common shares (representing 10.74% of its shares) to Halifax based Emera Inc. (EMA – TSX) for $7.40 per share.  Emera purchased the ICD Utilities (ICD) shares from MaruEnergy Grand Bahama Limited, an indirect subsidiary of Marubeni TAQA Caribbean Ltd., as part of a transaction announced on December 2nd. 

 In 2008 Emera Inc. acquired 50 per cent of ICD. Today’s closing increases Emera’s interest in ICDU from 50 to 60 per cent. The remaining 40 per cent of ICD is held by individual shareholders. Emera also now owns majority interest (80.4 per cent) of Grand Bahama Power Limited.

 About ICD Utilities Limited

 ICD Utilities Limited (”ICD”) is a holding company incorporated under the laws of the Commonwealth of The Bahamas for the purpose of ownership of a 50% shareholding of Grand Bahama Power Company Limited.  ICD is listed on the Bahamas International Securities Exchange under the symbol ICD.  Prior to this transaction Emera Inc. owned 50% of ICD.

 About Emera Inc.

 (EMA and EMA.PR.A -TSX) is an energy and services company with $5.8 billion Canadian dollars in assets. Electricity is Emera’s core business. Approximately 94% of Emera’s revenues are earned by Nova Scotia Power Inc (NSPI), Bangor Hydro Electric Company (BHE) and the Brunswick Pipeline. NSPI and BHE are wholly-owned regulated electric utilities which together serve 603,000 customers. The Brunswick Pipeline is a 145 km gas pipeline in New Brunswick. Emera also owns Maine and Maritimes Corporation, the parent company of Maine Public Service Company, a regulated electric utility serving approximately 36,000 electricity customers in Northern Maine and MAM Services Group. In the Caribbean, Emera owns 19% of St. Lucia Electricity Services Limited, which serves more than 50,000 customers on the island of St. Lucia, 80.4% of Grand Bahama Power Company which serves 19,000 customers on the island of Grand Bahama and 38% of Light & Power Holdings, which serves 120,000 customers on the island of Barbados through its regulated electric utility, The Barbados Light and Power Company. In addition to its electric utility investments, Emera owns Bayside Power, a 260 MW gas-fired power plant in Saint John, New Brunswick; Emera Energy Services, a physical natural gas and power marketing and asset management business; a joint venture interest in Bear Swamp, a 600 megawatt pumped storage hydro-electric facility in northern Massachusetts; a 12.9% interest in the Maritimes & Northeast Pipeline; and an 8.2% interest in Open Hydro.

 

Click Here for More Information »